Pfizer (PFE) BioNTech (BNTX) will stop US COVID-19 vaccine study in healthy adults ages 50 to 64 due to slow enrollment
Importance
Level 1
#PFIZER INC#PFE.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#PFE#US EQUITIES